organization · Reporting owner
BioPlus Sponsor LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioPlus Acquisition Corp.BIOS · Entity 112459 | 10% owner | June 05, 2023 | June 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioPlus Acquisition Corp.
Report date June 05, 2023 · Filed June 12, 2023
Jointly reported with Explorer Parent LLC, Founder Holdings LLC, VIEUX ALEX SERGE, Fletcher Steven C.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary SharesSEC Table I · non-derivative | IndirectSee footnote | 6,629,999 |
Reported balance
After 2023-06-05 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-06-05 · Conversion · Acquired 5,749,999 · Balance 6,629,999 F1: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F2: Includes (i) 380,000 placement units purchased by BioPlus Sponsor LLC (the "Sponsor") for $10.00 per unit in a private placement transaction with the Issuer and (ii) a Sponsor loan in the amount of $5,000,000 that is convertible into 500,000 additional units. Each such unit consists of one Class A Ordinary Share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction. F3: The Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of the Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein. |
| Class B Ordinary SharesSEC Table II · derivative / convertible security | IndirectSee footnote | 1 |
Reported balance
After 2023-06-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-05 · Conversion · Disposed 5,749,999 · Balance 1 F1: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F3: The Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of the Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares.
F2: Includes (i) 380,000 placement units purchased by BioPlus Sponsor LLC (the "Sponsor") for $10.00 per unit in a private placement transaction with the Issuer and (ii) a Sponsor loan in the amount of $5,000,000 that is convertible into 500,000 additional units. Each such unit consists of one Class A Ordinary Share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction.
F3: The Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of the Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2023 Filed Jun 12, 2023 21:17 UTC | BioPlus Acquisition Corp. BIOS · Entity 112459 | ConversionClass B Ordinary Shares · Derivative | 5,749,999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-015416 · doc4.xml · derivative · entry 2 BioPlus Sponsor LLC · CIK 0001895859 · 10% owner Explorer Parent LLC · CIK 0001814906 · 10% owner Founder Holdings LLC · CIK 0001814907 · 10% owner VIEUX ALEX SERGE · CIK 0001188069 · 10% owner Fletcher Steven C. · CIK 0001804143 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1 Underlying: Class A Ordinary Shares · 5,749,999 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F1 · kind: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F1 · price: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F1 · derivative.exercise_date: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F1 · derivative.expiration_date: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of the Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 05, 2023 Filed Jun 12, 2023 21:17 UTC | BioPlus Acquisition Corp. BIOS · Entity 112459 | ConversionClass A Ordinary Shares | 5,749,999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-015416 · doc4.xml · nonDerivative · entry 1 BioPlus Sponsor LLC · CIK 0001895859 · 10% owner Explorer Parent LLC · CIK 0001814906 · 10% owner Founder Holdings LLC · CIK 0001814907 · 10% owner VIEUX ALEX SERGE · CIK 0001188069 · 10% owner Fletcher Steven C. · CIK 0001804143 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 6,629,999 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F1 · price: The shares of Class B ordinary shares, par value $0.0001 per share ("Class B Ordinary Shares"), of the issuer are convertible into an equal number of shares of Class A ordinary shares, par value $0.0001 per share ("Class A Ordinary Shares"), of the issuer and have no expiration date. On June 5, 2023, the reporting person elected to convert 5,749,999 of their Class B Ordinary Shares into an equal number of Class A Ordinary Shares. F2 · balance_after: Includes (i) 380,000 placement units purchased by BioPlus Sponsor LLC (the "Sponsor") for $10.00 per unit in a private placement transaction with the Issuer and (ii) a Sponsor loan in the amount of $5,000,000 that is convertible into 500,000 additional units. Each such unit consists of one Class A Ordinary Share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of the Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by the Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 17:35 UTC | BioPlus Acquisition Corp. BIOS · Entity 112459 | OtherSponsor Loan · Derivative | Not disclosed | $5,000,000.00 Strike: $10.00 | $5,000,000.00 |
DisclosureSEC source: 0001567619-21-021723 · doc1.xml · derivative · entry 2 BioPlus Sponsor LLC · CIK 0001895859 · 10% owner Explorer Parent LLC · CIK 0001814906 · 10% owner Founder Holdings LLC · CIK 0001814907 · 10% owner VIEUX ALEX SERGE · CIK 0001188069 · Director Fletcher Steven C. · CIK 0001804143 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: Not disclosed Underlying: Class A ordinary shares · 500,000 shares Expires not disclosed F3 · kind: The Sponsor Loan is convertible at the option of Sponsor into Sponsor Loan Units at a conversion price of $10.00 per unit at any time up until the consummation of the Issuer's business combination transaction. Each Sponsor Loan Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction F3 · derivative.exercise_date: The Sponsor Loan is convertible at the option of Sponsor into Sponsor Loan Units at a conversion price of $10.00 per unit at any time up until the consummation of the Issuer's business combination transaction. Each Sponsor Loan Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction F3 · derivative.expiration_date: The Sponsor Loan is convertible at the option of Sponsor into Sponsor Loan Units at a conversion price of $10.00 per unit at any time up until the consummation of the Issuer's business combination transaction. Each Sponsor Loan Unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction F2 · ownership.nature: Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| December 07, 2021 Filed Dec 7, 2021 17:35 UTC | BioPlus Acquisition Corp. BIOS · Entity 112459 | OtherClass A ordinary shares | 380,000 | $10.00 | $3,800,000.00 |
DisclosureSEC source: 0001567619-21-021723 · doc1.xml · nonDerivative · entry 1 BioPlus Sponsor LLC · CIK 0001895859 · 10% owner Explorer Parent LLC · CIK 0001814906 · 10% owner Founder Holdings LLC · CIK 0001814907 · 10% owner VIEUX ALEX SERGE · CIK 0001188069 · Director Fletcher Steven C. · CIK 0001804143 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 380,000 F1 · kind: Consists of 380,000 placement units purchased by BioPlus Sponsor LLC ("Sponsor") for $10.00 per unit in a private placement transaction with the Issuer. Each such unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The warrants will become exercisable 30 days after the completion of the Issuer's business combination transaction. F2 · ownership.nature: Sponsor is the record holder of the securities reported herein. Alex Vieux and Steven Fletcher are managing members of Sponsor and of Founder Holdings LLC, which is the managing member of Explorer Parent LLC, which is a member of Sponsor. By virtue of these relationships, each of these entities and individuals may be deemed to share beneficial ownership of the securities held of record by Sponsor. Each of them disclaims any such beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.